Skip Navigation

European Heart Journal 2003 24(10):970-976; doi:10.1016/S0195-668X(03)00005-8
Copyright © 2003 by the European Society of Cardiology.
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (17)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bolger, A. P
Right arrow Articles by Gatzoulis, M. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolger, A. P
Right arrow Articles by Gatzoulis, M. A
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Regular Articles

Congenital heart disease: the original heart failure syndrome

Aidan P Bolgera,b,*, Andrew J.S Coatsb and Michael A Gatzoulisa

a Adult Congenital Heart Programme, Royal Brompton Hospital, London, UK
b Department of Clinical Cardiology, National Heart and Lung Institute, Dovehouse Street, London SW3 6LY, UK

* Corresponding author. Tel.: +44-20-7351-8127; fax: +44-20-7351-8733
E-mail address: a.bolger{at}ic.ac.uk

Received 4 October 2002; accepted 10 December 2002

Heart failure is characterised by a triad comprising cardiac abnormality, exercise limitation and neurohormonal activation. The 2% of the adult population who suffer with heart failure are known to derive both symptomatic and prognostic benefit from exercise and pharmacologic neurohormonal antagonism. The existence of heart failure has traditionally been considered in the context of ischaemic, hypertensive, valvular and myopathic disease but in this article we develop the argument that patients with congenital heart disease also manifest all the pathophysiological criteria that constitute the chronic heart failure syndrome. We discuss the inherent limitations to a purely anatomical approach to congenital heart disease, bring attention to the large and rapidly growing population of adults with this condition and conclude by calling for a therapeutic approach to congenital heart disease that is based on the heart failure paradigm.

Key Words: Congenital heart disease • Heart failure • Neurohormonal activation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. Hoashi, G. Matsumiya, S. Miyagawa, H. Ichikawa, T. Ueno, M. Ono, A. Saito, T. Shimizu, T. Okano, N. Kawaguchi, et al.
Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart.
J. Thorac. Cardiovasc. Surg., August 1, 2009; 138(2): 460 - 467.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
K. Dimopoulos, D. O. Okonko, G.-P. Diller, C. S. Broberg, T. V. Salukhe, S. V. Babu-Narayan, W. Li, A. Uebing, S. Bayne, R. Wensel, et al.
Abnormal Ventilatory Response to Exercise in Adults With Congenital Heart Disease Relates to Cyanosis and Predicts Survival
Circulation, June 20, 2006; 113(24): 2796 - 2802.
[Abstract] [Full Text] [PDF]

Home page
 EuropaceHome page
G.-P. Diller, D. Okonko, A. Uebing, S. Y. Ho, and M. A. Gatzoulis
Cardiac resynchronization therapy for adult congenital heart disease patients with a systemic right ventricle: analysis of feasibility and review of early experience.
Europace, April 1, 2006; 8(4): 267 - 272.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Janousek, V. Tomek, V. Chaloupecky, O. Reich, R. A. Gebauer, J. Kautzner, and B. Hucin
Cardiac resynchronization therapy: A novel adjunct to the treatment and prevention of systemic right ventricular failure
J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1927 - 1931.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.